SCN Incubation Investment Award: Stage 1 Application Form

SCN Incubation Investment Award (IIA) Application Process

• SCN’s Incubation Investment Award (IIA) Program is targeted to Canadian pre-seed and seed-staged regenerative medicine companies.
• As described in the IIA Program Guidelines found on SCN’s website, pre-seed and seed-staged companies that would like to be considered for an Incubation Investment Award, will undergo a two-staged evaluation and selection process:
  • Stage 1: Submission of the Stage 1 IIA Application Form and non-confidential pitch deck, for eligibility, company staging and investment potential assessment.
  • Stage 2: Confidential due diligence.
• To enter Stage 1, companies must complete this application form and upload their non-confidential pitch deck by the submission deadline (Friday, September 26, 2025 at 11:59 p.m. Pacific Time). SCN will confirm receipt within 48 hours; applicants are responsible for following up if no confirmation is received.
• Submission of the Stage 1 IIA Application Form and non-confidential pitch deck is mandatory. SCN will assess eligibility, stage of development, and the company’s potential for success within the IIA Program.
• IIA applications are encouraged from Indigenous people, women, people with disabilities, racialized people, and 2SLGBTQIA+ people.
• Applicants that are successful in moving from Stage 1 to Stage 2 of the IIA process will be notified by Wednesday, October 22, 2025.
• No reviewer feedback will be provided for Stage 1 of the application process. Only companies participating in Stage 2 of the application process will receive reviewer evaluation and feedback comments.
• If you have additional questions:
  • Refer to the Frequently Asked Questions posted on the SCN’s website
  • View the IIA informational webinar posted on SCN’s YouTube channel
  • Email SCN at researchSCN@stemcellnetwork.ca

Timeline

• Competition opens Monday, September 8, 2025, at which point all key information for the Stage 1 application process will be available on SCN's website. 
• Stage 1 Application submission deadline is Friday, September 26, 2025, at 11:59 p.m. Pacific Time.
• Applicants will be notified by Wednesday, October 22, 2025, if they have been selected to move forward with Stage 2 of the application process.

Instructions

• Definitions and instructions are provided on a per question basis.
• Please do not include any confidential information or trade secrets during Stage 1 of the application process.
• The IIA Program supports high-potential regenerative medicine companies at both pre-seed and seed stages. Some questions in the application are geared towards more mature companies; please answer these questions to the best of your ability. All information provided during the Stage 1 application process will be reviewed in detail again during the Stage 2 evaluation and selection process, for invited companies.
• Non-confidential pitch decks should be submitted in PDF format and should be 10 (min) to 20 (max) slides in length. Non-confidential pitch decks should describe, at minimum, the technology, the team, and refer to the company strategy to advance the technology, and to advance the company (e.g. timelines, financing requirements, etc).
• You can save your progress by clicking the "Save" button at the end of the form (Section 7). After clicking save, you will be prompted to either sign-up for a Jotform account, or you can click "Skip Create an Account" and either enter your email to get a link sent to your inbox, or click "Get Draft Link" to copy the link which you can save locally.

IIA_FY26